Historical record - last NADAC effective date: 4/19/2023

Product Information

OXYMORPHONE HCL 5 MG TABLET is a generic product labeled by KVK-Tech Inc., priced at $0.5201 per EA under NDC 10702007001. Its NADAC has been published 542 times since Nov 28, 2013.

FDA first approved this application on Jan 30, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OXYMORPHONE HCL 5 MG TABLET

Oxymorphone Hydrochloride
$0.5201per EA
DEA Schedule CII

Strength

5 mg/1

Manufacturer

KVK-Tech Inc.

NDC

10702007001

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

4/19/2023

Active Ingredients

OXYMORPHONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA203601

FDA Approved

1/30/2013

TE Code

AB

On Market Since

2/11/2013

Pharmacological Classes

Full Opioid Agonists
Opioid Agonist

Price Statistics

The NADAC for OXYMORPHONE HCL 5 MG TABLET has been published 542 times since Nov 28, 2013, and over the history we have for it it has declined 74.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5201 per EA
All-time high$2.1959 (Jan 15, 2014)
All-time low$0.3420 (Sep 23, 2020)
Median price$0.9216
Average price$1.0244
Largest weekly change+123.9% (Dec 23, 2020)
Weeks tracked542
Tracking sinceNov 28, 2013

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

0.0%

5Y

+38.3%

All

-74.6%

Last surveyed Apr 10, 2024 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of OXYMORPHONE HCL 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for OXYMORPHONE HCL 5 MG TABLET, manufactured by KVK-Tech Inc., is $0.5201 per EA (NDC 10702007001), effective Apr 10, 2024.

How has the price of OXYMORPHONE HCL 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for OXYMORPHONE HCL 5 MG TABLET has declined 74.6%. It has been tracked across 542 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for OXYMORPHONE HCL 5 MG TABLET?

Since Nov 28, 2013, the NADAC for OXYMORPHONE HCL 5 MG TABLET has ranged from a low of $0.3420 (Sep 23, 2020) to a high of $2.1959 (Jan 15, 2014), with a median of $0.9216 per EA.

Are there cheaper alternatives to OXYMORPHONE HCL 5 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OXYMORPHONE HCL 5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures OXYMORPHONE HCL 5 MG TABLET?

OXYMORPHONE HCL 5 MG TABLET (NDC 10702007001) is labeled by KVK-Tech Inc., and CMS classifies it as a generic product.